Professor of Medicine, Penn State College of Medicine
Cardiology
Dr. Gerald V. Naccarelli, MD
|
|
Give Review
Gerald Naccarelli practices Cardiology. He studied medicine at Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care He received awards:"America's Top Doctors" and "Fellow (FACC)". Gerald Naccarelli is a published doctor and has 59 publications published. The lastest was: 'Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry.
- Practical Management Guide for Clinicians Who Treat Patients with Amiodarone.
- Heart rate is associated with progression of atrial fibrillation, independent of rhythm.
- Tricuspid Valve Incompetence Following Implantation of Ventricular Leads.
- Late onset of exercise induced focal ventricular tachycardia originating from the ventricular end of an A-V accessory pathway after elimination of conduction.
- Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in su...
- The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS.
- Dronedarone: an alternate choice to sotalol and amiodarone in the treatment of atrial fibrillation/flutter in patients who have coronary Heart disease.
- Clinical significance of increased tricuspid Valve incompetence following implantation of ventricular leads.
- Clinical Efficacy of Dofetilide for the Treatment of Atrial Tachyarrhythmias in Adults with Congenital Heart Disease.
- Rate versus rhythm control for management of Atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibri...
- Appropriate and Inappropriate Use of Dronedarone in 2013.
- Catheter ablation of Atrial fibrillation: the need for studies to assess the efficacy and safety of novel anticoagulants.
- The Food and Drug Administration Decision Not to Approve the 110 Mg Dose of Dabigatran: Give Us a Way Out.
- Using Dabigatran in Patients With Stroke: A Practical Guide for Clinicians.
- Rates and Implications for Hospitalization of Patients ???65 Years of Age With Atrial Fibrillation/Flutter.
- Dofetilide reduces the frequency of ventricular Arrhythmias and implantable cardioverter defibrillator therapies.
- Post-ATHENA and beyond.
- A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
- Treatment of Atrial fibrillation in 2010 and beyond.
- Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic Atrial fibrillation: a randomized controlled trial.
- Cardiac resynchronization therapy: evaluation of ventricular dysynchrony and patient selection.
- Optimizing the management of Atrial fibrillation: focus on current guidelines and the impact of new agents on future recommendations.
- Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with Atrial fibrillation/Atrial flutter in the United States.
- The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: a survey of current knowledge and practice supporting the need f...
- Increasing prevalence of Atrial fibrillation and flutter in the United States.
- Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic Atrial fibrillation: a prospective study.
- Efficacy and safety of dofetilide in patients with Atrial fibrillation and Atrial flutter.
- Device therapies in the post-Myocardial infarction patient with left ventricular dysfunction.
- Atrial fibrillation and the expanding role of catheter ablation: do antiarrhythmic drugs have a future?
- Pathophysiology and Disease progression of atrial fibrillation: importance of achieving and maintaining sinus rhythm.
- Ambulatory electrocardiographic monitoring: has mobile cardiac outpatient telemetry changed the playing field?
- Paroxysmal atrioventricular block following a ventricular premature beat.
- Fast-track training of nonelectrophysiologists to implant defibrillators: is it needed?
- Can incremental innovation of implantable cardioverter-defibrillator systems become disruptive to patient care? Moore's law gone awry.
- Antiarrhythmic drug therapy for Atrial fibrillation: are the guidelines guiding clinical practice?
- Post Myocardial infarction, left ventricular dysfunction, and the expanding role of cardiac implantable electrical devices.
- Selection of drugs in pursuit of rate control strategy.
- Antiadrenergic therapy in the control of Atrial fibrillation.
- Carvedilol's antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction.
- Does it make sense to train plumbers as electricians?
- Can we predict antiarrhythmic efficacy or inefficacy of amiodarone or any other antiarrhythmic? What this patient needs is a doctor!
- Working group 1: How to increase the output of cardiologists.
- Implantable cardioverter-defibrillators: expanding indications.
- Complications of biventricular pacing.
- Role of intracardiac ultrasound in interventional electrophysiology.
- Advances in the treatment of Atrial fibrillation: the future is now.
- Atrial fibrillation in Heart failure: prognostic significance and management.
- A review of clinical trials assessing the efficacy and safety of newer antiarrhythmic drugs in Atrial fibrillation.
- Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in Atrial fibrillation: comparative efficacy and results of trials.
- Atrial fibrillation in patients with Heart failure.
- Arrhythmias in Patients with Heart Failure.
- ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/...
- Maintaining stability of sinus rhythm in Atrial fibrillation: antiarrhythmic drugs versus ablation.
- Entrainment of ventricular tachycardia with a permanent biventricular pacemaker.
- Left ventricular Aneurysm as a consequence of hypertrophic obstructive cardiomyopathy.
- Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials.
- Biventricular pacing in congestive Heart failure: a boost toward finer living.
Schools
Pennsylvania State University College Of Medicine
North Carolina Baptist Hospital
Hershey Med Center
Indiana University Med Center
Procedures Preformed
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Clinical Cardiac Electrophysiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerihealth
- Assurant Health
- Blue Card PPO
- Capital Blue Cross
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Gateway Health Plan
- Geisinger Health Plan
- Golden Rule
- Medicare Advantage PFFS
- HealthPartners
- Community Blue PPO
- Humana
- Kaiser Permanente
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medicare MCR
- Medico
- PHCS Network PPO
- Mutual of Omaha
- National Elevator
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
- UPMC Health Plan
Awards
- America's Top Doctors
- Fellow (FACC)
Education
-
Indiana University School of Medicine -
Penn State University -
Wake Forest University -
Penn State College of Medicine
Hospital
-
Penn State Milton S. Hershey Medical Center
Drug Facts
| NPI NUMBER | 1730137407 | |
| NPPES Provider LastName | NACCARELLI | |
| NPPES Provider FirstName | GERALD | |
| NPPES Provider ZIPCode | 170332360 | |
| NPPES Provider State | PA | |
| Specialty Description | Cardiac Electrophysiology | |
| Total Claim Count | 377.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730137407 |
| Last Name Of The Provider | NACCARELLI |
| First Name Of The Provider | GERALD |
| View All |
Similar Doctors
|
|
Dr. Charles E. Chambers, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joy C. Cotton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward B. Lankford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William R. Davidson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Urs A. Leuenberger, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Edward G. Liszka II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald Maag, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan Logue, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mauricio Sendra Ferrer, MD
This Doctor is OpenDoctor Recommended.
|